Partnership to Protect Coverage issues a statement encouraging all states to use Medicaid flexibilities to ensure patients have ample opportunity to respond to redetermination requests, and to minimize disruptions in their health coverage.
Site Search
CF Foundation sends a letter to Amerigroup and New Jersey Medicaid asking the groups to update their Trikafta® eligibility criteria to reflect the recent label expansion to people with CF between ages two and five.
Coalition letter asking Georgia’s governor to pause Medicaid procedural terminations to ensure that those who are currently enrolled in Medicaid can maintain their coverage, if eligible, or transition to other forms of coverage.
The letter responds to Select Health’s changes in coverage criteria, urging the health plan to cover Trikafta for all people with cystic fibrosis who meet eligibility requirements per the U.S. Food and Drug Administration label.
Ad hoc patient advocacy coalition letter to the Center for Medicare and Medicaid Services on the implementation of the Medicare Part D maximum monthly out-of-pocket cap option.
Partnership for Protecting Coverage statement urging the Administration to take immediate action to protect patients’ Medicaid coverage amid the public health emergency unwinding.
CF Foundation letter to the Wisconsin governor thanking him for funding the Wisconsin Chronic Disease Program and Wisconsin Medicaid in the 2023-2025 biennial budget.
Partnership for Protecting Coverage letter to the U.S. Department of Health and Human Services outlining patient priorities for the 2025 Notice of Benefits and Payment Parameters.
CF Foundation letter to the Ohio governor and state legislature thanking them for funding the Children and Youth with Special Health Needs program and Ohio Medicaid in the 2024-2025 budget.
CF Foundation letter to the Senate Finance Committee in support of the Modernization and Ensuring PBM Accountability Act which would enhance accountability and address the opaque influence of pharmacy benefit managers.